All Stories

  1. Bacillus subtilis engineered for topical delivery of an antifungal agent
  2. An ultra-low-cost electroporator with microneedle electrodes (ePatch) for SARS-CoV-2 vaccination
  3. Fabrication of pure-drug microneedles for delivery of montelukast sodium
  4. Thermostability of Measles and Rubella Vaccines in a Microneedle Patch
  5. Efficient Drug Delivery into Skin Using a Biphasic Dissolvable Microneedle Patch with Water‐Insoluble Backing
  6. Serum Protects Cells and Increases Intracellular Delivery of Molecules by Nanoparticle-Mediated Photoporation
  7. Administration of pilocarpine by microneedle patch as a novel method for cystic fibrosis sweat testing
  8. Dissolvable Microneedle Patches to Enable Increased Access to Vaccines against SARS-CoV-2 and Future Pandemic Outbreaks
  9. Fabrication of microneedle patches with lyophilized influenza vaccine suspended in organic solvent
  10. Sensitive sensing of biomarkers in interstitial fluid
  11. Sampling interstitial fluid from human skin using a microneedle patch
  12. Relationship between bio-effects and energy transduction during nanoparticle-mediated photoporation
  13. STAR particles for enhanced topical drug and vaccine delivery
  14. Long-acting reversible contraception by effervescent microneedle patch
  15. Microneedle patch drug delivery in the gut
  16. Targeting drug delivery within the suprachoroidal space
  17. Extended delivery of vaccines to the skin improves immune responses
  18. Plasmonic Paper Microneedle Patch for On-Patch Detection of Molecules in Dermal Interstitial Fluid
  19. Pharmaceutical jewelry: Earring patch for transdermal delivery of contraceptive hormone
  20. Co-Delivery of M2e Virus-Like Particles with Influenza Split Vaccine to the Skin Using Microneedles Enhances the Efficacy of Cross Protection
  21. Electrospun Transdermal Patch for Contraceptive Hormone Delivery
  22. Monitoring drug pharmacokinetics and immunologic biomarkers in dermal interstitial fluid using a microneedle patch
  23. Rapidly separable microneedle patch for the sustained release of a contraceptive
  24. Recruitment and Collection of Dermal Interstitial Fluid Using a Microneedle Patch
  25. Development of a thermostable microneedle patch for polio vaccination
  26. Self-healing encapsulation and controlled release of vaccine antigens from PLGA microparticles delivered by microneedle patches
  27. Vaccination by microneedle patch with inactivated respiratory syncytial virus and monophosphoryl lipid A enhances the protective efficacy and diminishes inflammatory disease after challenge
  28. Hepatitis B vaccination using a dissolvable microneedle patch is immunogenic in mice and rhesus macaques
  29. Heterosubtypic influenza protection elicited by double-layered polypeptide nanoparticles in mice
  30. Enhanced Immune Responses Conferring Cross-Protection by Skin Vaccination With a Tri-Component Influenza Vaccine Using a Microneedle Patch
  31. Intradermal immunization by Ebola virus GP subunit vaccines using microneedle patches protects mice against lethal EBOV challenge
  32. Effect of laser fluence, nanoparticle concentration and total energy input per cell on photoporation of cells
  33. Individually coated microneedles for co-delivery of multiple compounds with different properties
  34. Intradermal Vaccination With Adjuvanted Ebola Virus Soluble Glycoprotein Subunit Vaccine by Microneedle Patches Protects Mice Against Lethal Ebola Virus Challenge
  35. Drug delivery using microneedle patches: not just for skin
  36. Ocular drug delivery targeted by iontophoresis in the suprachoroidal space using a microneedle
  37. A Microneedle Patch for Measles and Rubella Vaccination Is Immunogenic and Protective in Infant Rhesus Macaques
  38. Mechanisms of sampling interstitial fluid from skin using a microneedle patch
  39. Stable incorporation of GM-CSF into dissolvable microneedle patch improves skin vaccination against influenza
  40. Human Suction Blister Fluid Composition Determined Using High-Resolution Metabolomics
  41. The suprachoroidal space as a route of administration to the posterior segment of the eye
  42. Inactivated rotavirus vaccine by parenteral administration induces mucosal immunity in mice
  43. Photoporation Using Carbon Nanotubes for Intracellular Delivery of Molecules and Its Relationship to Photoacoustic Pressure
  44. Dihydroergotamine mesylate-loaded dissolving microneedle patch made of polyvinylpyrrolidone for management of acute migraine therapy
  45. Skin immunization by microneedle patch overcomes statin-induced suppression of immune responses to influenza vaccine
  46. Iontophoretic targeting of drug delivery in the eye via the suprachoroidal space
  47. A boosting skin vaccination with dissolving microneedle patch encapsulating M2e vaccine broadens the protective efficacy of conventional influenza vaccines
  48. The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial
  49. Microneedle patch delivery of influenza vaccine during pregnancy enhances maternal immune responses promoting survival and long-lasting passive immunity to offspring
  50. Role of cytoskeletal mechanics and cell membrane fluidity in the intracellular delivery of molecules mediated by laser‐activated carbon nanoparticles
  51. Engineering Microneedle Patches for Vaccination and Drug Delivery to Skin
  52. Tolerability, usability and acceptability of dissolving microneedle patch administration in human subjects
  53. Energy Transfer Mechanisms during Molecular Delivery to Cells by Laser-Activated Carbon Nanoparticles
  54. Challenges and Future Prospects for the Delivery of Biologics: Oral Mucosal, Pulmonary, and Transdermal Routes
  55. Clearance Kinetics and Clearance Routes of Molecules From the Suprachoroidal Space After Microneedle Injection
  56. Thickness and Closure Kinetics of the Suprachoroidal Space Following Microneedle Injection of Liquid Formulations
  57. Evaluation of Microneedles in Human Subjects
  58. Distribution of particles, small molecules and polymeric formulation excipients in the suprachoroidal space after microneedle injection
  59. Targeted Drug Delivery Within the Eye Through the Suprachoroidal Space
  60. Ebola Vaccination Using a DNA Vaccine Coated on PLGA-PLL/γPGA Nanoparticles Administered Using a Microneedle Patch
  61. Microneedle patches for vaccination in developing countries
  62. Rabies vaccination in dogs using a dissolving microneedle patch
  63. Tetanus vaccination with a dissolving microneedle patch confers protective immune responses in pregnancy
  64. DNA uptake, intracellular trafficking and gene transfection after ultrasound exposure
  65. Circumferential flow of particles in the suprachoroidal space is impeded by the posterior ciliary arteries
  66. Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma
  67. Long-term stability of influenza vaccine in a dissolving microneedle patch
  68. Intracellular delivery of molecules using microfabricated nanoneedle arrays
  69. Enhanced Stability of Inactivated Influenza Vaccine Encapsulated in Dissolving Microneedle Patches
  70. Inkjet printing of transdermal microneedles for the delivery of anticancer agents
  71. Enhanced immune responses by skin vaccination with influenza subunit vaccine in young hosts
  72. Inactivated polio vaccination using a microneedle patch is immunogenic in the rhesus macaque
  73. A microneedle patch containing measles vaccine is immunogenic in non-human primates
  74. An economic model assessing the value of microneedle patch delivery of the seasonal influenza vaccine
  75. Formulation to target delivery to the ciliary body and choroid via the suprachoroidal space of the eye using microneedles
  76. Lidocaine-ibuprofen ionic liquid for dermal anesthesia
  77. Effect of Osmotic Pressure on the Stability of Whole Inactivated Influenza Vaccine for Coating on Microneedles
  78. Microneedle patch delivery to the skin of virus-like particles containing heterologous M2e extracellular domains of influenza virus induces broad heterosubtypic cross-protection
  79. Delivery of siRNA to ovarian cancer cells using laser-activated carbon nanoparticles
  80. Development of a Thermostable Microneedle Patch for Influenza Vaccination
  81. Microneedle patches: Usability and acceptability for self-vaccination against influenza
  82. Measles vaccination using a microneedle patch
  83. Targeted Drug Delivery to the Eye Enabled by Microneedles
  84. Delivery Systems for Intradermal Vaccination
  85. Microneedle-Based Vaccines
  86. Microneedles for Drug Delivery
  87. Microneedles
  88. Assessment of Microneedles for Transdermal Drug Delivery
  89. Microfabricated Microneedles for Transdermal Drug Delivery
  90. Macromolecules as Novel Transdermal Transport Enhancers for Skin Electroporation
  91. Recent Advances in Skin Electroporation: Mechanism and Efficacy
  92. The Effects of Pulsed Electrical Protocols on Skin Damage, Sensation, and Pain
  93. Transdermal Delivery of Macromolecules: Recent Advances by Modification of Skin's Barrier Properties
  94. Electrical Impedance Spectroscopy for Rapid and Noninvasive Analysis of Skin Electroporation
  95. Mechanistic Studies of Skin Electroporation Using Biophysical Methods